CN Stock MarketDetailed Quotes

301230 PharmaResources

Watchlist
  • 27.64
  • +0.67+2.48%
Market Closed Nov 15 15:00 CST
3.86BMarket Cap552.80P/E (TTM)

About PharmaResources Company

Established in 2007, the company is a one-stop integrated service provider for R&D and commercial production of innovative small-molecule drugs. It is committed to drug discovery, pharmaceutical process research and development, and commercial production of APIs and intermediates. The company is a one-stop comprehensive service provider for new drug development and commercial production. It is committed to drug discovery, pharmaceutical process research and development, and commercial production of API intermediates. The company's main products and businesses: Drug discovery includes pharmaceutical chemistry research, synthetic chemistry research and pharmacokinetics research; process research and development includes process chemistry and process development and CMC research on APIs; commercial production includes customized production of new drugs (CMO) and R&D, production and sales of independent generic drug products.

Company Profile

Short Name-A泓博医药
Symbol-A301230
Company NamePharmaResources (Shanghai) Co., Ltd.
Listing DateNov 1, 2022
Issue Price40.00
Shares Offered19.25M share(s)
FoundedDec 14, 2007
Legal RepresentativePING CHEN
General ManagerPING CHEN
Secretaryshengli jiang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativeqiuli li
Legal CounselBeijing Jiayuan Law Firm
Employees1012
Phone021-50720100
Office AddressBuilding 12, No. 59, Kaiqing Road, Pudong District, Shanghai
Zip Code201201
Registered AddressBuilding 23, No. 315, Qingda Road, Pudong District, Shanghai
Fax021-50720097-266
Emailinfo@pharmaresources.cn
Business License310115400237574
BusinessResearch and development of new drugs and related biotechnology, transfer of own technology, and provision of relevant technical services and advice (for projects requiring approval according to law, business activities can only be carried out after approval by relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • PING CHEN
  • Chairman, Directors, General Manager, Chairman of the Strategy and Investment Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
  • 1.10M
  • rongchang an
  • Directors, Audit Committee Member
  • --
  • shengli jiang
  • Directors, Board Secretary, Deputy General Manager, Member of the Strategy and Investment Committee
  • --
  • zheng fei
  • Directors
  • --
  • qidong you
  • Independent Directors, Chairman of the Nomination Committee, Member of the Strategy and Investment Committee
  • 200.00K
  • li cheng
  • Independent Directors, Chairman of the Audit Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
  • 200.00K
  • chunyang shao
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
  • 200.00K
  • qiuli li
  • Securities Affairs Representative
  • --
  • guodong liu
  • Chairman of the Supervisory Board, Auditors
  • --
  • huizu wang
  • Auditors
  • --
  • xuejun dong
  • Auditors
  • 403.60K
  • ZHEN-WEI CAI
  • Deputy General Manager
  • 1.14M
  • haifeng li
  • Deputy General Manager
  • 1.20M
  • shicheng li
  • Chief Financial Officer
  • 538.70K
  • xiaojing he
  • Employee Supervisors
  • 474.10K
  • peihua sun
  • Employee Supervisors
  • 861.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data